Skip to content
Search

Latest Stories

COVID-19: PM announces extra £46m funding package to fight virus

Prime Minister Boris Johnson today announced a £46 million funding package for urgent work to find a COVID-19 vaccine and develop a rapid test for the disease.

The announcement builds on the plan set out by the Prime Minister earlier this week to tackle the disease in the country.


This sum is in addition to the £30 million commitment that the UK has already made to the Coalition for Epidemic Preparedness Innovations (CEPI).

The latest funding package includes support for the World Health Organisation’s Flash Appeal and will also help vulnerable countries prepare for the spread of coronavirus in other ways.

It brings the UK’s total support to fight the virus internationally to £91 million and the investment into COVID-19 vaccine research to £65 million.

Prime Minister Boris Johnson said: “Keeping the British people safe is my number one priority, and that’s why I’ve set out our four-part plan to contain, delay, mitigate and research coronavirus.”

We are ensuring the country is prepared for the current outbreak, guided by the science at every stage. But we also need to invest now in researching the vaccines that could help prevent future outbreaks.”

The Prime Minister has visited the Mologic Laboratory in the Bedford technology Park,  where British scientists are working on ways to diagnose coronavirus.

“I’m very proud that UK experts – backed by government funding – are on the front line of global efforts to do just that,” he said.

Supported by UK funding, eight possible coronavirus vaccines are currently under development and efforts are being made to get any viable vaccines from sequencing of the virus to clinical testing in under a year. Governments around the world could then work with pharmaceutical companies to get vaccines into production and use.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less